Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director

          Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent DirectorOctober 31, 2025 10:15 AM EDT | Source: Phio Pharmaceuticals Corp.King of Prussia, Pennsylvania--(Newsfile Corp. - October 31, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio is pleased to announce that David Deming has been ap ...